Board meetings, strategic plans, and buyer signals from Jennifer L. Bryant’s organization
Jun 25, 2026·BoardMeeting
Board
Medical Cannabis Advisory Board Policy Group Meeting Minutes
The meeting focused on organizational updates, including leadership transitions and the introduction of a new director for the Office of Medical Cannabis. Program metrics were reviewed, highlighting support for 35,661 patients and the achievement of a 100 percent completion rate for quarterly facility inspections. Key discussions also included regulatory updates on cannabis products, federal rescheduling efforts, and new emergency restrictions limiting Kratom products to their natural leaf form.
Mar 23, 2023·BoardMeeting
Board
Medical Cannabis Advisory Board Quarterly Meeting
The meeting included a welcome to the new commissioner of the Bureau for Public Health, Dr. Matt Christensen, and an update on his background and priorities. The board discussed public comments from the previous meeting, mainly concerning opposition to a THC cap. An update was provided on the office's activities, including patient applications, approvals, registered physicians, sales, and industry operations. Legislative updates were given, including discussions on bills related to medical and recreational cannabis, as well as industrial hemp. The board also discussed concerns related to youth use and the importance of counseling pregnant mothers on the risks of cannabis exposure.
Sep 8, 2022·BoardMeeting
Board
Medical Cannabis Advisory Board Meeting
The meeting addressed public comments, clarified the distinction between the Office of Medical Cannabis and the Medical Cannabis Advisory Board, and discussed social media threats made to a board member. An update was provided on the progress of the Office, including metrics on applications received and approved, operational growers and dispensaries, cannabis sales, and revenue. The Health of Medical Work Group summarized their previous meeting, focusing on THC potency and potential public health concerns. There was discussion regarding capping THC content in dispensed products, with concerns raised about the impact on patients and the industry.
Aug 16, 2022·BoardMeeting
Board
Medical Cannabis Advisory Board Health and Medical Workgroup Meeting
The meeting of the Medical Cannabis Advisory Board Health and Medical Workgroup included a presentation by Dr. Libby Stout on potential THC limits for cannabis products. Discussions covered public comment formats and the consideration of public input before workgroup votes. Dr. Stout shared insights from Colorado's experience with high-potency THC, discussing the benefits, risks, and consequences associated with cannabis use, including potential impacts on mood regulation, brain development, addiction, and mental health.
Extracted from official board minutes, strategic plans, and video transcripts.
Enterprise
Get verified public-sector contacts at scale
Find verified emails, direct dials, role context, job-change updates, and organization signals across every public-sector account you sell to.
